FoxP3 gene polymorphism is associated with breast cancer in Iranian patients

Summary. Aim: Breast cancer (BC) is one of the leading causes of cancer death among women. Recent studies have characterized FoxP3 as a marker of regulatory T cells and an X-linked tumor suppressor gene, which is involved in the pathogenesis of BC. Therefore, we investigated the potential influence...

Повний опис

Збережено в:
Бібліографічні деталі
Дата:2018
Автори: Arabpour, F., Shafizad, A., Rahimzadeh, M., Norouzian, M., Naderi, N.
Формат: Стаття
Мова:English
Опубліковано: PH Akademperiodyka 2018
Теми:
Онлайн доступ:https://exp-oncology.com.ua/index.php/Exp/article/view/2018-4-8
Теги: Додати тег
Немає тегів, Будьте першим, хто поставить тег для цього запису!
Назва журналу:Experimental Oncology

Репозитарії

Experimental Oncology
id oai:ojs2.ex.aqua-time.com.ua:article-286
record_format ojs
spelling oai:ojs2.ex.aqua-time.com.ua:article-2862025-04-30T11:55:13Z FoxP3 gene polymorphism is associated with breast cancer in Iranian patients FoxP3 gene polymorphism is associated with breast cancer in Iranian patients Arabpour, F. Shafizad, A. Rahimzadeh, M. Norouzian, M. Naderi, N. breast cancer, FOXP3, polymorphism, Treg cells breast cancer, FOXP3, polymorphism, Treg cells Summary. Aim: Breast cancer (BC) is one of the leading causes of cancer death among women. Recent studies have characterized FoxP3 as a marker of regulatory T cells and an X-linked tumor suppressor gene, which is involved in the pathogenesis of BC. Therefore, we investigated the potential influence of three single-nucleotide polymorphisms (SNPs) of FoxP3 gene on the development of BC in Iranian women. Materials and Methods: The association between FoxP3 rs2232365, rs3761548 and rs4824747 polymorphisms and BC risk was assessed in 124 BC patients and 198 healthy controls using sequence-specific primers. Results: We identified significant difference of rs3761548 in both allele and genotype frequencies between cases and control groups. Our results showed that individuals carrying FoxP3 rs3761548 AA genotype had about 4.3-fold increased risk of BC compared with CC carriers. No significant association was found between rs3761548C>A polymorphism and clinical outcome parameters (age of onset, tumor size, lymph nodes metastasis, tumor stage, progesterone receptor status, estrogen receptor status, Ki-67 status, HER-2 status and duration of disease). Conclusion: This study has provided the first genetic data on the FoxP3 gene polymorphism in south of Iran and proposes the rs3761548 polymorphism of FoxP3 gene as a risk factor, but not a prognostic marker in the development of BC in Iranian population. Summary. Aim: Breast cancer (BC) is one of the leading causes of cancer death among women. Recent studies have characterized FoxP3 as a marker of regulatory T cells and an X-linked tumor suppressor gene, which is involved in the pathogenesis of BC. Therefore, we investigated the potential influence of three single-nucleotide polymorphisms (SNPs) of FoxP3 gene on the development of BC in Iranian women. Materials and Methods: The association between FoxP3 rs2232365, rs3761548 and rs4824747 polymorphisms and BC risk was assessed in 124 BC patients and 198 healthy controls using sequence-specific primers. Results: We identified significant difference of rs3761548 in both allele and genotype frequencies between cases and control groups. Our results showed that individuals carrying FoxP3 rs3761548 AA genotype had about 4.3-fold increased risk of BC compared with CC carriers. No significant association was found between rs3761548C>A polymorphism and clinical outcome parameters (age of onset, tumor size, lymph nodes metastasis, tumor stage, progesterone receptor status, estrogen receptor status, Ki-67 status, HER-2 status and duration of disease). Conclusion: This study has provided the first genetic data on the FoxP3 gene polymorphism in south of Iran and proposes the rs3761548 polymorphism of FoxP3 gene as a risk factor, but not a prognostic marker in the development of BC in Iranian population. PH Akademperiodyka 2018-12-22 Article Article application/pdf https://exp-oncology.com.ua/index.php/Exp/article/view/2018-4-8 Experimental Oncology; Vol. 40 No. 4 (2018): Experimental Oncology; 309-314 Експериментальна онкологія; Том 40 № 4 (2018): Експериментальна онкологія; 309-314 2312-8852 1812-9269 en https://exp-oncology.com.ua/index.php/Exp/article/view/2018-4-8/2018-4-8 Copyright (c) 2023 Experimental Oncology https://creativecommons.org/licenses/by-nc/4.0/
institution Experimental Oncology
baseUrl_str
datestamp_date 2025-04-30T11:55:13Z
collection OJS
language English
topic breast cancer
FOXP3
polymorphism
Treg cells
spellingShingle breast cancer
FOXP3
polymorphism
Treg cells
Arabpour, F.
Shafizad, A.
Rahimzadeh, M.
Norouzian, M.
Naderi, N.
FoxP3 gene polymorphism is associated with breast cancer in Iranian patients
topic_facet breast cancer
FOXP3
polymorphism
Treg cells
breast cancer
FOXP3
polymorphism
Treg cells
format Article
author Arabpour, F.
Shafizad, A.
Rahimzadeh, M.
Norouzian, M.
Naderi, N.
author_facet Arabpour, F.
Shafizad, A.
Rahimzadeh, M.
Norouzian, M.
Naderi, N.
author_sort Arabpour, F.
title FoxP3 gene polymorphism is associated with breast cancer in Iranian patients
title_short FoxP3 gene polymorphism is associated with breast cancer in Iranian patients
title_full FoxP3 gene polymorphism is associated with breast cancer in Iranian patients
title_fullStr FoxP3 gene polymorphism is associated with breast cancer in Iranian patients
title_full_unstemmed FoxP3 gene polymorphism is associated with breast cancer in Iranian patients
title_sort foxp3 gene polymorphism is associated with breast cancer in iranian patients
title_alt FoxP3 gene polymorphism is associated with breast cancer in Iranian patients
description Summary. Aim: Breast cancer (BC) is one of the leading causes of cancer death among women. Recent studies have characterized FoxP3 as a marker of regulatory T cells and an X-linked tumor suppressor gene, which is involved in the pathogenesis of BC. Therefore, we investigated the potential influence of three single-nucleotide polymorphisms (SNPs) of FoxP3 gene on the development of BC in Iranian women. Materials and Methods: The association between FoxP3 rs2232365, rs3761548 and rs4824747 polymorphisms and BC risk was assessed in 124 BC patients and 198 healthy controls using sequence-specific primers. Results: We identified significant difference of rs3761548 in both allele and genotype frequencies between cases and control groups. Our results showed that individuals carrying FoxP3 rs3761548 AA genotype had about 4.3-fold increased risk of BC compared with CC carriers. No significant association was found between rs3761548C>A polymorphism and clinical outcome parameters (age of onset, tumor size, lymph nodes metastasis, tumor stage, progesterone receptor status, estrogen receptor status, Ki-67 status, HER-2 status and duration of disease). Conclusion: This study has provided the first genetic data on the FoxP3 gene polymorphism in south of Iran and proposes the rs3761548 polymorphism of FoxP3 gene as a risk factor, but not a prognostic marker in the development of BC in Iranian population.
publisher PH Akademperiodyka
publishDate 2018
url https://exp-oncology.com.ua/index.php/Exp/article/view/2018-4-8
work_keys_str_mv AT arabpourf foxp3genepolymorphismisassociatedwithbreastcanceriniranianpatients
AT shafizada foxp3genepolymorphismisassociatedwithbreastcanceriniranianpatients
AT rahimzadehm foxp3genepolymorphismisassociatedwithbreastcanceriniranianpatients
AT norouzianm foxp3genepolymorphismisassociatedwithbreastcanceriniranianpatients
AT naderin foxp3genepolymorphismisassociatedwithbreastcanceriniranianpatients
first_indexed 2025-07-17T12:17:25Z
last_indexed 2025-07-17T12:17:25Z
_version_ 1844164863190892544